Modular Medical Launches Digital Tools to Support Pivot Insulin Pump Adoption

SAN DIEGO, October 15, 2026 /CourierPR/ -- Modular Medical, a company focused on innovative insulin delivery technologies, has launched two new digital learning tools aimed at supporting the adoption of its Pivot tubeless patch pump. The tools, developed in partnership with Relevate Health Games, use game-based technology to help patients and healthcare providers familiarize themselves with insulin pump therapy.

The first tool, a 15-minute virtual walkthrough of the Pivot insulin delivery system, allows prospective users to practice key steps in a low-pressure environment before formal training. This resource was first previewed at the ADCES 2025 Annual Conference in August 2025.

Healthcare providers can also use the platform to gauge a patient's interest in pump therapy and ability to navigate basic operational tasks. The experience offers clinicians valuable insight into patient engagement, learning readiness, and willingness to transition from multiple daily injections to a more advanced insulin delivery approach.

Modular Medical and Relevate Health Games are also expanding diabetes education through gaming by launching a Pivot module inside Level One: A Diabetes Game, the free Type 1 diabetes education game developed and published by Relevate Health Games. Since its launch in April 2025, Level One has been downloaded more than 53,000 times and is supported by leading Type 1 diabetes organizations, including Breakthrough T1D and Beyond Type 1.

The new Pivot module builds on the foundation of Level One's core gameplay, which centers on mealtime insulin dosing. Once players have mastered the fundamentals of mealtime dosing, they take on the same challenges with the Pivot pump, experiencing firsthand how the device fits into the dosing decisions they have already learned to make and how pump therapy can become a natural, helpful part of everyday diabetes care.

Modular Medical's Pivot pump is designed to offer a simplified approach to insulin delivery for individuals requiring intensive insulin therapy. The company's vision extends beyond device innovation, aiming to build practical educational tools that make advanced insulin therapy more approachable.